
Biography
Luc began his career at Bankers Trust, as Vice-President and Regional Sales Manager, Northern Europe. He was a Board Director of Schroders plc from 2006 until 2015. He has been with Ackermans & van Haaren as a director since 1985, where he joined as financial director in 1986 and was chairman of the executive committee from 1990 to 2016. He is chairman of the board of directors of CFE, DEME and SIPEF and a director of Delen Private Bank, JM Finn, Bank J.Van Breda & C° and Verdant Bioscience. He is also chairman of the Duve Institute and Middelheim Promoters, member of a number of other boards of directors of non-profit associations and public institutions, such as Museum Mayer van den Bergh and Europalia, member of the board of trustees of Guberna and member of the general board of the Institute of Tropical Medicine. He has served as a NED on our Board since 2011 and became Chairman in 2024.
Q2 has been marked by significant market volatility, writes Investment Director Simon Temple-Pedersen. Despite geopolitical tensions and the S&P 500's dramatic swing, quality businesses are adaptable…
Andrew Mann explores the significant decline in the US dollar's value in 2025, examining the factors driving this weakness and its implications for UK investors.
Investment Director Charles Bathurst-Norman covers the salient points from Q2 2025: Trump is pressuring the US Federal Reserve to cut rates, while tax rises in the UK appear to be on the cards.